Positive Psychology in Suicidal Patients (POPS)

August 1, 2016 updated by: University Hospital, Montpellier

Effectiveness of Positive Psychology in Suicidal Patients: A Randomized Controlled Trial

Suicide is a major health concern. Weeks following psychiatric admission are a highly suicide risk period for those having current suicidal ideation or attempt. Recently, a pilot study suggested the feasibility of positive psychology in patients in suicidal crisis. Notably, gratitude exercises suggested improvement in optimism and hopelessness, two dimensions associated to suicide. Moreover, gratitude has been associated to suicidal ideation and attempt, independently from depression. Thus, investigators want to conduct the first randomized controlled study in order to assess effectiveness of gratitude exercises (vs control task) in suicidal inpatients, on 1) psychological pain reduction 2) suicidal ideation, hopelessness, optimism, depressive symptomatology, and anxiety improvement.

Study Overview

Detailed Description

Study design: monocentric randomized controlled study

Methods:

206 inpatients (Department of Emergency Psychiatry and Post Acute Care), between 18 and 65 years-old, having attempted suicide before hospitalisation or having current active suicidal ideation at the time of the psychiatric hospitalisation. Patients suffering from schizophrenia are excluded.

Randomization into two groups: Positive Psychology (i.e., gratitude journal) (n = 103) or Control Task (i.e., food journal) (n = 103), daily exercises during 7 days (in add-on from usual treatment).

Clinical assessment: 1) at baseline (the day before the intervention beginning) (V0); 2) short daily self-assessments (immediately before and after the exercise); 3) the day following the last day of the intervention (V1).

  • V0 : socio-demographic data, treatments, psychopathology, suicidal ideation,depressive and anxious symptomatology, psychological pain, optimism, hopelessness.
  • Daily self-assessments: psychological pain, optimism, hopelessness
  • V1 : treatments suicidal ideation,depressive and anxious symptomatology, psychological pain, optimism, hopelessness, intervention satisfaction.

Study Type

Interventional

Enrollment (Anticipated)

206

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion criteria:

  • Being hospitalized for suicidal thoughts or suicide attempt (from less than a week)
  • Having signed informed consent
  • Be fluent in French
  • Able to understand nature, aims and methodology of the study

Exclusion criteria:

  • Lifetime history of schizophrenia according to the Diagnostic and Statistical Manual of Mental Disorders - V (DSM-V) criteria
  • Current eating disorder according to DSM-V criteria
  • Patient on protective measures (guardianship or trusteeship)
  • Deprived of liberty subject (judicial or administrative decision)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention group
Positive Psychology (gratitude journal)

Gratitude Journal (Emmons and Stern, 2013)

Every evening, patients have to write down the things they feel grateful about.

Placebo Comparator: Control group
Alimentary list

Food journal (i.e. alimentary list):

Patients have to write down the list of foods eaten during the day.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Psychological pain reduction using a likert scale
Time Frame: At the inclusion and day 8 (the day after the end of the intervention)
Psychological pain reduction, in gratitude vs control group, between the beginning and the end of the intervention, using a likert scale.
At the inclusion and day 8 (the day after the end of the intervention)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Psychological pain reduction using a likert scale
Time Frame: At day 1, 2, 3, 4, 5, 6, 7
Psychological pain reduction, in gratitude vs control group, the beginning and the end of each exercise, using a likert scale.
At day 1, 2, 3, 4, 5, 6, 7
intensity of suicidal ideation
Time Frame: At the inclusion and day 8 (the day after the end of the intervention)
Reduction of suicidal ideation intensity, in gratitude vs control group between the beginning and the end of the intervention using a Likert Scale and the Scale for Suicidal Ideation (SSI).
At the inclusion and day 8 (the day after the end of the intervention)
Intensity of hopelessness
Time Frame: At the inclusion and day 8 (the day after the end of the intervention)
Reduction of hopelessness, in gratitude vs control group between the beginning and the end of the intervention, using a Likert Scale and the Beck Hopelessness Scale (BHS).
At the inclusion and day 8 (the day after the end of the intervention)
Intensity of optimism
Time Frame: At the inclusion and day 8 (the day after the end of the intervention)
Reduction of hopelessness, in gratitude vs control group between the beginning and the end of the intervention, using a Likert Scale and the Life Orientation Test-Revised (LOT-R).
At the inclusion and day 8 (the day after the end of the intervention)
Intensity of depressive symptoms using the Beck Depression Inventory (BDI)
Time Frame: Day 8 (the day after the end of the intervention)
Reduction of depressive symptoms between the beginning and the end of the intervention, using the Beck Depression Inventory (BDI)
Day 8 (the day after the end of the intervention)
Intensity of anxious symptoms using the State Anxiety Inventory- State (SAI-State)
Time Frame: Day 8 (the day after the end of the intervention)
Reduction of anxious symptoms between the beginning and the end of the intervention, using the State Anxiety Inventory- State (SAI-State)
Day 8 (the day after the end of the intervention)
Perceived usefulness of the intervention using a likert scale
Time Frame: Day 8 (the day after the end of the intervention)
Evaluation of the perceived usefulness of each intervention, using a likert scale.
Day 8 (the day after the end of the intervention)
Intensity of suicidal ideation
Time Frame: At day 1, 2, 3,4 5, 6, 7
Reduction of suicidal ideation intensity, in gratitude vs control group between the beginning and the end of each exercise, using a Likert Scale.
At day 1, 2, 3,4 5, 6, 7
Intensity of hopelessness
Time Frame: At day 1, 2, 3, 4, 5, 6, 7
Reduction of hopelessness, in gratitude vs control group between the beginning and the end of each exercise, using a Likert Scale.
At day 1, 2, 3, 4, 5, 6, 7
Intensity of optimism
Time Frame: At day 1, 2, 3, 4, 5, 6, 7
Reduction of hopelessness, in gratitude vs control group between the beginning and the end of each exercise, using a Likert Scale.
At day 1, 2, 3, 4, 5, 6, 7

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2015

Primary Completion (Anticipated)

April 1, 2017

Study Completion (Anticipated)

July 1, 2017

Study Registration Dates

First Submitted

July 8, 2016

First Submitted That Met QC Criteria

August 1, 2016

First Posted (Estimate)

August 4, 2016

Study Record Updates

Last Update Posted (Estimate)

August 4, 2016

Last Update Submitted That Met QC Criteria

August 1, 2016

Last Verified

July 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • UF 9557
  • 2015-A00358-41 (Other Identifier: FRANCE: Agence Nationale de Sécurité des Médicaments)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Suicidal Thoughts

Clinical Trials on Positive Psychology

Subscribe